phrykt

ENDRA Life Sciences Inc. (NDRA): who owns it and who trades it

As of Nov 16, 2026, no open-market insider purchases or sales of NDRA were reported in the last 12 months. 2 of the 50 famous funds we follow held it at their last quarter end.

Latest filing Nov 16, 2026. From Form 4, 13F and Schedule 13D/G filings.

At a glance

Insider trades

No NDRA insider reported an open-market purchase or sale in the last 12 months.

Purchases, 12 months
$0
0 trades, 0 people
Sales, 12 months
$0
0 trades, 0 people
Sales under a 10b5-1 plan
–
Share of sale value
Latest trade
–
What this data shows, and what it doesn't
  • Shows: open-market purchases and sales by officers, directors and 10%+ owners, reported on Form 4 within two business days of the trade.
  • Leaves out: stock awards, option exercises, shares withheld for tax and gifts. These are not trades at a market price chosen by the insider.
  • "plan" marks a sale made under a Rule 10b5-1 plan, a schedule set up in advance.
  • Fund holders come from 13F reports, a snapshot at quarter end filed up to 45 days later.
  • Filings are self-reported and can be amended. Each trade links to its original filing. Methodology

NDRA short interest

Low short interest. 1.6% of NDRA shares are sold short: about 1 share in 64. Over the last 12 reports the number of shares short went down 29%.

As a rough guide, under 5% is low, 5–10% is moderate, 10–20% is high and over 20% is very high.

0%5%10%15%20%+

As of Oct 30, 2026, 23,275 NDRA shares were sold short, 1.6% of the shares outstanding, down 3.4% from the report before. At the average daily volume of 11,825 shares, buying them all back would take about 2.0 trading days (days to cover).

Shares short, % of all shares

1.55%May 15Oct 303.67%

Days to cover

2.0May 15Oct 302.7

Every report

Settlement dateShares short% of sharesChangeAvg daily volumeDays to cover
Oct 30, 202623,2751.55%-3%11,8252.0
Oct 15, 202624,0871.61%-15%17,6291.4
Sep 30, 202628,2331.88%-10%49,3071.0
Sep 15, 202631,3402.09%-1%78,9741.0
Aug 31, 202631,6152.11%+5%12,8762.5
Aug 14, 202630,0782.01%-9%16,9961.8
Jul 31, 202632,9472.66%+19%18,9141.7
Jul 15, 202627,6352.23%-34%36,7641.0
Jun 30, 202642,1193.39%+92%81,3301.0
Jun 15, 202621,9041.77%+11%14,8101.5
May 29, 202619,8201.60%-39%18,0841.1
May 15, 202632,6032.63%-12%15,6962.1

Short sellers borrow shares and sell them, hoping to buy them back for less. A high number means many such bets are open. It does not say where the price will go. Source: FINRA equity short interest, reported by brokers twice a month (positions on the 15th and the last business day) and published about 7 business days later. % of shares uses the share count on the company's latest SEC filing. What short interest means · Most shorted stocks

ENDRA Life Sciences company events

ENDRA Life Sciences filed 11 reports on Form 8-K in the last 12 months, 5 of them about an important change (leadership, control, job cuts). The latest was on Oct 1, 2026.

  1. Oct 1, 2026AgreementFirst Amendment to Agreement and Plan of Merger As previously disclosed, on June 25, 2026, ENDRA Life Sciences Inc., a Delaware corporation, entered into an Agreement and Plan of Merger, by and among ASP Isotopes Inc., a Delaware corporation, Noble Africa LLC, a Delaware limited liability company… Filing
  2. Aug 17, 2026ResultsReleased financial results. Filing
  3. Jul 9, 2026AnnouncementAs previously disclosed, on April 20, 2026, The Nasdaq Stock Market LLC Listing Qualifications Staff issued a letter to ENDRA Life Sciences Inc. indicating that the Company’s stockholders’ equity as reported in its Annual Report on Form 10-K for the year ended December 31, 2025 was below the $2.5… Filing
  4. Jun 26, 2026ControlTo the extent required by this Item 5.01, the information included in Item 1.01 of this Current Report on Form 8-K is incorporated herein by reference. 4 Item 7.01. Filing
  5. Jun 25, 2026AnnouncementShared information with investors. Filing
  6. May 28, 2026AgreementENDRA Life Sciences Inc., a Delaware corporation, entered into a securities purchase agreement with an accredited investor pursuant to which the Company agreed to sell and issue to the Purchaser in a private placement offering an aggregate of 578,387 shares of common stock of the Company, par value… Filing
  7. Apr 21, 2026ListingAs previously reported, on May 27, 2025, the Company received a notification letter from The Nasdaq Stock Market LLC Listing Qualifications Staff notifying the Company that its stockholders’ equity had fallen below the $2.5 million required minimum for continued listing set forth in Nasdaq Listing… Filing
  8. Mar 31, 2026ResultsReleased financial results. Filing
  9. Mar 25, 2026Job cutsAnnounced job cuts or other exit costs. Filing
  10. Dec 15, 2025LeadershipThe stockholders of ENDRA Life Sciences Inc. approved the Second Amendment to the Company’s 2016 Omnibus Incentive Plan at the 2025 Annual Meeting of the Company’s Stockholders. Filing
  11. Nov 28, 2025LeadershipDeparture of Directors or Certain Officers; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. Filing

From 8-K reports, which a company must file within 4 business days of an important event. Where a report is about a change such as a new CEO, the sentence is the first one from the report itself, shortened. Each row links to the original filing. Company events this week

ENDRA Life Sciences financials

Famous investors that hold NDRA

2 of the 50 well-known investors we track reported holding NDRA in their latest 13F filing. The largest position is Ken Griffin's, worth $124K.

FundQuarterSharesValueOf portfolioChange
Ken Griffin · Citadel AdvisorsQ3 202620,745$124K0.0%-31%
Jim Simons · Renaissance TechnologiesQ3 202618,764$112K0.0%New

From 13F reports: a snapshot at quarter end, filed up to 45 days later. Change compares with the quarter before.

5%+ stakes filed in the last 120 days

Anyone who owns more than 5% of a company must report it on Schedule 13D or 13G. 4 filings named NDRA in the last 120 days.

FiledHolderFormStake
Nov 10, 2026Salt Rock Capital Partners LLP13G7.4%
Nov 10, 2026Salt Rock Capital Partners LLP13G7.4%
Oct 8, 2026ASP Isotopes Inc.13D15.1%
Oct 8, 2026ASP Isotopes Inc.13D15.1%

Questions about ENDRA Life Sciences Inc. (NDRA) stock

Are NDRA insiders buying or selling?

No NDRA insider reported an open-market purchase or sale on Form 4 in the last 12 months. Share awards, option exercises and gifts are not counted.

What is the short interest in NDRA?

As of Oct 30, 2026, 23,275 NDRA shares were sold short, 1.6% of the shares outstanding, down 3.4% from the report before. At the average daily volume of 11,825 shares, buying them all back would take about 2.0 trading days (days to cover). See the history.

Which famous investors hold NDRA?

2 of the 50 well-known investors we track reported NDRA in their latest 13F filing, including Ken Griffin, Jim Simons. The largest position is worth $124K. See all holders.

Source: SEC Form 4 (insiders, filed within 2 business days), 13F (funds, up to 45 days after quarter end) and Schedule 13D/13G filings. Only open-market purchases (code P) and sales (code S) are shown. Data only, not investment advice. How we collect it.